Imagine losing your memories, your ability to recognize loved ones, or even perform daily tasks that once felt second nature. This is the painful reality for over 7 million Americans living with ...

Only four trials measured side effects systematically. We concluded that there are significant gaps in the evidence needed to guide decisions about medicines for sleeping problems in dementia. More ...

Dementia care represents a significant burden to our society. Although we are still far from any cure for dementia, there are several medications available for symptomatic management of Alzheimer ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

These tests can help sort out vascular dementia from other types of dementia and Alzheimer disease. Lumbar puncture (Spinal tap). This is done to analyze cerebrospinal fluid for inflammation, ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ago, experts from both fields will select the most promising drugs for both ...

There is little training in end of life care for people with dementia, with dementia still often not being accepted as an illness which will lead to death, requiring any form of specialist end of life ...

News UK & World News Alzheimer's disease Two drugs that treat Alzheimer's rejected for use on NHS due to cost The drugs target the cause of the disease but their use could cost the NHS £1bn a year ...

There was no difference in conversion to AD dementia between the treatment and control groups after 2 years; however, at 1 year, there were fewer conversions from LMCI to AD dementia in the IVIG group ...